切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2020, Vol. 09 ›› Issue (01) : 41 -45. doi: 10.3877/cma.j.issn.2095-3232.2020.01.009

所属专题: 文献

临床研究

意外胆囊癌诊治的单中心回顾性分析
董晓骅1, 杨晓军2,()   
  1. 1. 750000 宁夏回族自治区银川市,宁夏医科大学临床医学院
    2. 730000 兰州,甘肃省人民医院普外二科
  • 收稿日期:2019-09-13 出版日期:2020-02-10
  • 通信作者: 杨晓军
  • 基金资助:
    国家自然科学基金(81660398)

Diagnosis and treatments of incidental gallbladder cancer: a single-center retrospective analysis

Xiaohua Dong1, Xiaojun Yang2,()   

  1. 1. School of Clinical Medicine, Ningxia Medical University, Yinchuan 750000, China
    2. Department Ⅱ of General Surgery, Gansu Provincial Hospital, Lanzhou 73000, China
  • Received:2019-09-13 Published:2020-02-10
  • Corresponding author: Xiaojun Yang
  • About author:
    Corresponding author: Yang Xiaojun, Email:
引用本文:

董晓骅, 杨晓军. 意外胆囊癌诊治的单中心回顾性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 09(01): 41-45.

Xiaohua Dong, Xiaojun Yang. Diagnosis and treatments of incidental gallbladder cancer: a single-center retrospective analysis[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2020, 09(01): 41-45.

目的

探讨意外胆囊癌(IGBC)的诊断与治疗。

方法

回顾性分析2013年1月至2018年3月在甘肃省人民医院行腹腔镜胆囊切除术(LC)的27例IGBC患者临床资料。其中男4例,女23例;年龄38~83岁,中位年龄62岁。术前诊断为胆囊结石24例,胆囊息肉3例。患者均签署知情同意书,符合医学伦理学规定。分析IGBC的临床特征和诊治方法。生存分析采用Log-rank检验。

结果

同期行LC的患者共6 585例,IGBC占0.41%(27/6 585),其中术中检出3例,术后检出24例;其中Tis期7例,T1b期3例,T2a期4例,T3期12例,T4期1例。术中检出3例均一期行胆囊癌根治术,10例二期行胆囊癌根治术。Tis、T1、T2、T3+T4期患者中位生存期分别为45、45、13、9个月,行胆囊癌根治术与非胆囊癌根治术患者中位生存期分别为32、17个月,不同肿瘤分期及手术方式的患者间生存差异有统计学意义(χ2=21.061,4.440;P<0.05)。

结论

术中病理检查有利于IGBC及早发现,提供优化首次手术方案的机会,避免二次手术。IGBC患者预后与手术方式、病理分期密切相关。

Objective

To investigate the diagnosis and treatments of incidental gallbladder cancer (IGBC).

Methods

Clinical data of 27 IGBC patients undergoing laparoscopic cholecystectomy (LC) in Gansu Provincial Hospital from January 2013 to March 2018 were retrospectively analyzed. Among them, 4 patients were male and 23 female, aged from 38 to 83 years with a median age of 62 years. 24 patients were diagnosed with gallbladder stones and 3 cases of gallbladder polyp before oprtation. The informed consents of all patients were obtained and the local ethical committee approval was received. The clinical characteristics, diagnosis and treatments of IGBC were analyzed. Survival analysis was performed by Log-rank test.

Results

A total of 6 585 patients underwent LC in the same period, and IGBC accounted for 0.41% (27/6 585). 3 cases were diagnosed with IGBC during the operation and 24 cases after the operation. Among them, 7 cases were diagnosed with IGBC Tis stage, and 3 with T1b, 4 with T2a, 12 with T3 and 1 with T4. The 3 patients who were diagnosed during the operation underwent radical resection of IGBC simultaneously and 10 cases received radical resection of IGBC in secondary operation. The median survival time of patients with Tis, T1, T2 and (T3+T4) stage IGBC was 45, 45, 13 and 9 months, respectively. The median survival time of patients undergoing radical resection and non-radical resection was 32 and 17 months. The survival time significantly differed between patients with different tumor stages and surgical approach (χ2=21.061 4.440; P<0.05).

Conclusions

Intraoperative pathological examination contributes to early detection of IGBC, provides an opportunity to optimize the primary surgical plan and avoids the secondary operation. Clinical prognosis of IGBC patients is significantly correlated with surgical approach and pathological stage.

图1 不同手术方式意外胆囊癌患者Kaplan-Meier生存曲线
表1 不同肿瘤分期及手术方式的IGBC患者生存分析
[1]
Benson AB, D'Angelica MI, Abbott DE, et al. Guidelines insights: hepatobiliary cancers, version 2.2019[J]. J Natl Compr Canc Netw, 2019, 17(4):302-310.
[2]
王刚,张龙辉,张长坤,等.不同手术方式治疗早期胆囊癌的临床疗效比较[J].中国普外基础与临床杂志,2017, 24(10):1220-1225.
[3]
Aldossary MY, Alayed AA, Amr SS, et al. Gallbladder cancer in Eastern Province of Saudi Arabia: a retrospective cohort study[J]. Ann Med Surg, 2018(35):117-123.
[4]
Pitt SC, Jin LX, Hall BL, et al. Incidental gallbladder cancer at cholecystectomy: when should the surgeon be suspicious?[J]. Ann Surg, 2014, 260(1):128-133.
[5]
Qadan M, Kingham TP. Technical aspects of gallbladder cancer surgery[J]. Surg Clin North Am, 2016, 96(2):229-245.
[6]
Kanthan R, Senger JL, Ahmed S, et al. Gallbladder cancer in the 21st century[J]. J Oncol, 2015:967472.
[7]
Xu WY, Zhang HH, Yang XB, et al. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients[J]. World J Gastroenterol, 2018, 24(13):1451-1463.
[8]
Wang YF, Feng FL, Zhao XH, et al. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer[J]. World J Gastroenterol, 2014, 20(14):4085-4092.
[9]
Aloreidi K, Zamulko A. Elevated vitamin B12: a rare presentation for gallbladder adenocarcinoma[J]. S D Med, 2018, 71(4):171-173.
[10]
Patkar S, Shinde RS, Kurunkar SR, et al. Radiological diagnosis alone risks overtreatment of benign disease in suspected gallbladder cancer: a word of caution in an era of radical surgery[J]. Indian J Cancer, 2017, 54(4):681-684.
[11]
Nitta T, Kataoka J, Ohta M, et al. Surgical strategy for suspected early gallbladder carcinoma including incidental gallbladder carcinoma diagnosed during or after cholecystectomy[J]. Ann Med Surg, 2018(33):56-59.
[12]
Tayeb M, Rauf F, Ahmad K, et al. Is it necessary to submit grossly normal looking gall bladder specimens for histopathological examination?[J]. Asian Pac J Cancer Prev, 2015, 16(4):1535-1538.
[13]
Koppatz H, Nordin A, Scheinin T, et al. The risk of incidental gallbladder cancer is negligible in macroscopically normal cholecystectomy specimens[J]. HPB, 2018, 20(5):456-461.
[14]
耿智敏,汤朝晖.2018年NCCN指南更新版胆囊癌诊治进展述评[J].西部医学,2018, 30(7):937-942, 947.
[15]
中国抗癌协会.胆囊癌规范化诊治专家共识(2016)[J].临床肝胆病杂志,2017, 33(4):611-620.
[16]
Tatli F, Ozgönül A, Yucel Y, et al. Incidental gallbladder cancer at cholecystectomy[J]. Ann Ital Chir, 2017(6):399-402.
[17]
Kasumova GG, Tabatabaie O, Najarian RM, et al. Surgical management of gallbladder cancer: simple versus extended cholecystectomy and the role of adjuvant therapy[J]. Ann Surg, 2017, 266(4):625-631.
[18]
Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies[J]. Surg Clin North Am, 2019, 99(2):337-355.
[19]
Aloia TA, Járufe N, Javle M, et al. Gallbladder cancer: expert consensus statement[J]. HPB, 2015, 17(8):681-690.
[20]
Yi X, Long X, Zai H, et al. Unsuspected gallbladder carcinoma discovered during or after cholecystectomy: focus on appropriate radical re-resection according to the T-stage[J]. Clin Transl Oncol, 2013, 15(8): 652-658.
[21]
Zhou D, Wang J, Quan Z, et al. Improvement in the diagnosis and treatment of T2 gallbladder carcinoma is pivotal to improvement in the overall prognosis for this disease[J]. Biosci Trends, 2019, 13(1): 1-9.
[22]
Sheikh MR, Osman H, Cheek S, et al. T2 gallbladder cancer-aggressive therapy is warranted[J]. Am Surg, 2016, 82(6): 518-521.
[23]
Vega EA, Vinuela E, Okuno M, et al. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors[J]. HPB, 2019, DOI: 10.1016/j.hpb.2018.12.006[Epub ahead of print].
[24]
Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location isa strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study[J]. Ann Surg, 2015, 261(4): 733-739.
[25]
锁涛,刘厚宝.意外胆囊癌的外科治疗[J/CD].中华肝脏外科手术学电子杂志,2016, 5(4): 206-208.
[26]
Hakeem AR, Papoulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer-a systematic review[J]. Eur J Surg Oncol, 2019, 45(2):83-91.
[27]
Shukla SK, Singh G, Shahi KS, et al. Staging, treatment, and future approaches of gallbladder carcinoma[J]. J Gastrointest Cancer, 2018, 49(1): 9-15.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[6] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[7] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[10] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[11] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[12] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[13] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[14] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?